WBRT plus SIB with IG-IMRT is a tolerable and effective treatment for NSCLC patients with inoperable brain metastases, especially for those with SIR score >5, number of intracranial lesions <3, and history of EGFR-TKI treatment. This evidence concerns the gene EGFR and non-small cell lung carcinoma.